Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Diabetes Care|June 12, 2016
NIH Precision Medicine Initiative: Implications for Diabetes ResearchJudith E Fradkin, Mary C Hanlon, Griffin P RodgersDiabetes|January 23, 2016
Type 1 Diabetes--Reaping the Rewards of a Targeted Research InvestmentJudith E Fradkin, Julie A Wallace, Beena Akolkar, et al.Health Affairs (Project Hope)|January 11, 2012
Confronting the urgent challenge of diabetes: an overviewJudith E FradkinOpen Forum Infectious Diseases|March 16, 2022
Olfactomedin 4 Is a Biomarker for the Severity of Infectious DiseasesWenli Liu, Griffin P RodgersBiochimica Et Biophysica Acta. Reviews on Cancer|August 20, 2025
Olfactomedin 4 in cancer development and progressionWenli Liu, Griffin P RodgersCancer Metastasis Reviews|May 15, 2016
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancerWenli Liu, Griffin P RodgersJournal of Diabetes and Its Complications|June 3, 2017
Intensive glycemic control in younger and older U.S. adults with type 2 diabetesSarah Casagrande, Catherine C Cowie, Judith E FradkinExperimental Hematology|August 17, 2004
Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell lineOlga P Zoueva, Griffin P RodgersCell Metabolism|February 13, 2021
COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research prioritiesWilliam T Cefalu, Griffin P RodgersBritish Journal of Haematology|June 25, 2015
HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell diseaseMartin H Steinberg, Griffin P RodgersPageof 8